IMMUNOME INC (IMNM)
US45257U1088 - Common Stock
Immunome Enters Oversold Territory (IMNM)
Immunome files to sell 21.7M shares for holders (NASDAQ:IMNM)
Immunome (IMNM) files prospectus for resale of 21.7 million common shares.
Immunome to Present at the Stifel 2023 Healthcare Conference
Immunome GAAP EPS of -$0.36, revenue of $3.57M (NASDAQ:IMNM)
Immunome reports Q3 financial results with a GAAP EPS of -$0.36 and revenue of $3.57M.
Immunome Reports Third Quarter 2023 Financial Results
Immunome Appoints Jean-Jacques Bienaimé to Board of Directors
7 Biotech Stocks to Get In Now Before Investors Catch On
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, KLR, IMNM
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMNM, CPRI, AVID
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Immunome Reports Second Quarter 2023 Financial Results
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
IMPORTANT ALERT: Halper Sadeh LLC Investigates DICE, IMNM, AJX
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Shareholder Alert: Ademi LLP investigates whether Immunome, Inc. has obtained a Fair Price in its Private Placement and its transaction with Morphimmune
/PRNewswire/ -- Ademi LLP is investigating Immunome (Nasdaq: IMNM) for possible breaches of fiduciary duty and other violations of law in its private placement...
IMNM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Immunome, Inc. Is Fair to Shareholders
Immunome and Morphimmune enter merger and a $125M private placement (NASDAQ:IMNM)
Biopharmaceutical company, Immunome (IMNM) and Morphimmune enter merger agreement, whereby the combined company, which will operate as Immunome and retain the same ticker symbol,...
Immunome Reports First Quarter 2023 Financial Results
Immunome Reports Fourth Quarter and Full Year 2022 Financial Results
Immunome to Present at 13th Annual World ADC London Conference
Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
AbbVie Briefly Breaks Out After Tapping Immunome In $30 Million Cancer Deal
AbbVie is tapping Immunome to help develop new cancer treatments.
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
/PRNewswire/ -- AbbVie (NYSE: ABBV) and Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biopharmaceutical company that utilizes its human memory B cell...